FGP timeline
Every FGP batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| FGP-2605-R8870 | Tirzepatide | 25 May 2026 | 2026-Q2 | 7 | 97.91 | 0.75 | 98.47 | +0.56 | |
| FGP-2604-K8509 | MK-677 (Ibutamoren mesylate) | 01 Apr 2026 | 2026-Q2 | 2 | 99.84 | 0.05 | 99.74 | -0.10 | |
| FGP-2603-L7753 | Tirzepatide | 16 Mar 2026 | 2026-Q3 | 3 | 98.81 | 0.35 | 99.24 | +0.43 | |
| FGP-2602-M7909 | Cagrilintide | 28 Feb 2026 | 2026-Q2 | 1 | 98.86 | n<2 | 98.35 | -0.51 | |
| FGP-2602-Y8741 | PT-141 (Bremelanotide) | 17 Feb 2026 | 2026-Q2 | 10 | 99.65 | 0.60 | 99.72 | +0.07 | |
| FGP-2602-M8547 | Semaglutide | 13 Feb 2026 | 2026-Q3 | 10 | 99.29 | 1.20 | 98.98 | -0.31 | |
| FGP-2601-V8281 | CJC-1295 (no DAC) | 16 Jan 2026 | 2026-Q2 | 3 | 99.83 | 0.31 | 99.70 | -0.13 | |
| FGP-2601-T8656 | TB-500 | 16 Jan 2026 | 2026-Q1 | 1 | 99.53 | n<2 | 99.81 | +0.28 | |
| FGP-2601-R8955 | SS-31 (Elamipretide) | 14 Jan 2026 | 2026-Q2 | 5 | 98.44 | 0.70 | 97.74 | -0.70 | SHARED BULK |
| FGP-2512-A9487 | BPC-157 | 24 Dec 2025 | 2026-Q1 | 3 | 99.93 | 0.04 | 99.90 | -0.03 | |
| FGP-2512-Y7789 | TB-500 | 07 Dec 2025 | 2026-Q2 | 7 | 99.85 | 0.36 | 99.90 | +0.05 | |
| FGP-2511-D8133 | Selank | 20 Nov 2025 | 2026-Q1 | 11 | 99.89 | 0.34 | 99.90 | +0.01 | |
| FGP-2508-R8995 | N-Acetyl Semax Amide | 23 Aug 2025 | 2025-Q3 | 2 | 98.81 | 0.73 | 98.57 | -0.24 | |
| FGP-2508-S8145 | TB-500 | 19 Aug 2025 | 2025-Q4 | 3 | 99.85 | 0.50 | 99.79 | -0.06 | |
| FGP-2506-L8855 | KPV | 16 Jun 2025 | 2025-Q3 | 8 | 99.88 | 0.26 | 99.38 | -0.50 | |
| FGP-2506-J7851 | Semaglutide | 02 Jun 2025 | 2025-Q4 | 12 | 99.93 | 1.05 | 99.90 | -0.03 | |
| FGP-2505-K8288 | PT-141 (Bremelanotide) | 25 May 2025 | 2025-Q4 | 2 | 98.78 | 0.01 | 98.29 | -0.49 | |
| FGP-2504-V8032 | Exenatide | 30 Apr 2025 | 2025-Q2 | 12 | 98.97 | 0.87 | 99.00 | +0.03 | |
| FGP-2503-P8516 | CJC-1295 (no DAC) | 01 Mar 2025 | 2025-Q1 | 4 | 99.27 | 0.55 | 99.90 | +0.63 | |
| FGP-2502-F7880 | MK-677 (Ibutamoren mesylate) | 03 Feb 2025 | 2025-Q2 | 7 | 99.32 | 0.57 | 99.43 | +0.11 | |
| FGP-2502-E8063 | NAD+ | 02 Feb 2025 | 2025-Q3 | 3 | 99.71 | 0.31 | 99.88 | +0.17 | |
| FGP-2501-A8957 | KPV | 30 Jan 2025 | 2025-Q2 | 1 | 99.82 | n<2 | 99.90 | +0.08 | |
| FGP-2501-G8414 | L-Carnosine | 22 Jan 2025 | 2025-Q1 | 4 | 99.75 | 0.37 | 99.90 | +0.15 | |
| FGP-2501-F8605 | SS-31 (Elamipretide) | 07 Jan 2025 | 2025-Q2 | 1 | 99.91 | n<2 | 99.79 | -0.12 | |
| FGP-2501-S8023 | Retatrutide | 01 Jan 2025 | 2025-Q1 | 5 | 98.76 | 0.87 | 98.71 | -0.05 | |
| FGP-2412-N8628 | Tirzepatide | 21 Dec 2024 | 2025-Q2 | 1 | 99.03 | n<2 | 98.78 | -0.25 | |
| FGP-2411-A8499 | MOTS-c | 24 Nov 2024 | 2024-Q4 | 5 | 99.81 | 0.18 | 99.62 | -0.19 | |
| FGP-2411-J8288 | GHRP-6 | 15 Nov 2024 | 2025-Q2 | 9 | 99.93 | 0.27 | 99.90 | -0.03 | |
| FGP-2410-J7714 | CJC-1295 (no DAC) | 16 Oct 2024 | 2024-Q4 | 5 | 99.46 | 0.48 | 99.44 | -0.02 | |
| FGP-2409-Y8596 | BPC-157 | 23 Sep 2024 | 2025-Q1 | 10 | 99.85 | 0.37 | 99.90 | +0.05 | |
| FGP-2409-W9076 | PT-141 (Bremelanotide) | 22 Sep 2024 | 2025-Q1 | 4 | 99.76 | 0.27 | 99.81 | +0.05 | |
| FGP-2408-H8588 | Tirzepatide | 28 Aug 2024 | 2024-Q4 | 1 | 99.23 | n<2 | 99.52 | +0.29 | |
| FGP-2408-K8560 | L-Glutathione (reduced) | 21 Aug 2024 | 2024-Q3 | 2 | 99.87 | 0.13 | 99.90 | +0.03 | |
| FGP-2408-S8496 | Dihexa | 19 Aug 2024 | 2025-Q1 | 10 | 99.59 | 0.54 | 99.78 | +0.19 | |
| FGP-2406-N8689 | Leuprolide | 20 Jun 2024 | 2024-Q3 | 3 | 99.53 | 0.18 | 99.25 | -0.28 | |
| FGP-2406-D8645 | Sermorelin | 02 Jun 2024 | 2024-Q3 | 3 | 99.44 | 0.22 | 99.43 | -0.01 | |
| FGP-2405-E9260 | L-Glutathione (reduced) | 21 May 2024 | 2024-Q3 | 12 | 99.59 | 0.67 | 99.90 | +0.31 | |
| FGP-2402-X8147 | TB-500 | 01 Feb 2024 | 2024-Q2 | 2 | 99.75 | 0.08 | 99.46 | -0.29 | |
| FGP-2312-X8684 | GHRP-6 | 01 Dec 2023 | 2024-Q2 | 6 | 99.56 | 0.43 | 99.51 | -0.05 |